This clinical trial is a comparative study designed to evaluate the accuracy and time
efficiency of an AI-enabled symptom summary tool in comparison to traditional medical
review methods in patients undergoing radiotherapy in the pelvic region.
Hypothesis:
The AI-enabled symptom summary tool is hypothesized to be non-inferior in accuracy to
traditional medical review methods and to save time in the process.
Primary Outcome:
Accuracy of Documentation: The quality of the documentation will be evaluated using the
Physician Documentation Quality Instrument-9 (PDQI-9), a validated questionnaire that
assesses nine key elements of documentation quality: completeness, correctness,
consistency, comprehensibility, relevance, organization, conciseness, formatting, and
overall impression. Blinded specialist doctors will use the PDQI-9 to evaluate both
AI-generated and traditional summaries, assigning scores from 1 to 10.
Secondary Outcomes:
Time Efficiency: The time required to complete the AI-enabled and traditional
consultations will be recorded and compared.
Physician Satisfaction: A custom-designed satisfaction questionnaire will be administered
to the physicians participating in the study. This questionnaire will include
Likert-scale questions to rate various aspects of satisfaction, including ease of use,
time efficiency, accuracy perception, and overall satisfaction.
Patient Satisfaction: A custom-designed satisfaction questionnaire will be administered
to the patients participating in the study. This questionnaire will include Likert-scale
questions to rate various aspects of satisfaction, including clarity and understanding,
perceived accuracy, engagement and interaction, and overall satisfaction.
Methodology:
Patient Selection: Patients meeting the inclusion criteria will be selected for
participation. Exclusion criteria will be applied to eliminate cases of pelvic
reirradiation or prior operations in the pelvic region.
Consultation Process: Patients will undergo a standard weekly consultation with a doctor.
In the same week, each patient will also have a separate consultation with a different
doctor. During this second consultation, a symptom questionnaire will be completed under
medical supervision. The resulting summary from this questionnaire will be generated
using the OpenAI GPT-4 API.
